TITLE:
      Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
SUMMARY:
      The purpose of this study is to compare the clinical efficacy of the buprenorphine/naloxone
      combination tablet to methadone for opioid maintenance treatment.
DETAILED DESCRIPTION:
      S/A brief "Summary for the Public"
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        Individuals must be at least 18 years of age, currently opioid dependent and meet FDA
        criteria for narcotic maintenance treatment. Co-morbid substance abuse or dependence
        disorders may also be present. Individuals must be healthy despite drug dependency.

        Exclusion Criteria:

        Individuals with evidence of an active Diagnostic and Statistical Manual of Mental
        Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness,
        organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular
        disease) or pregnant female subjects are excluded from study participation.
